Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasilez versus ramipril in moderate systolic hypertension
2009-011296-80Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of aliskiren and ramipril in isolated systolic hypertension (ISH) (2 arms), sponsored by Novartis. Primary endpoint: Change in mean sitting systolic blood pressure from baseline to final visit. Started May 2009; status: completed.
02
Drugs
aliskirenramipril
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on 2009-011296-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011296-80.